LVVV — Livewire Ergogenics Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- $1.12m
- $4.34m
- $0.58m
Annual cashflow statement for Livewire Ergogenics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2012 December 31st | 2013 December 31st | 2014 December 31st | 2019 December 31st | 2020 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.7 | -1.27 | -4.18 | -1.9 | -1.6 |
| Depreciation | |||||
| Non-Cash Items | 0.657 | 0.508 | 3.14 | 1.8 | 1.45 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.488 | 0.25 | 0.281 | -0.815 | 0.341 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.551 | -0.5 | -0.757 | -0.779 | 0.356 |
| Capital Expenditures | -0.017 | 0 | -0.005 | -0.011 | -0.041 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.009 | 0 | -0.023 | -0.579 | -0.833 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.008 | 0 | -0.028 | -0.59 | -0.874 |
| Financing Cash Flow Items | 0.042 | 0.047 | 0 | -0.054 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.53 | 0.506 | 0.779 | 1.34 | 0.628 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.029 | 0.006 | -0.007 | -0.028 | 0.11 |